RARA CRAFT DATABASE for FDA Medical Devices
510(k)K180011

FDA DEVICE FACTS

Pulmonx Chartis Tablet Console

Pulmonx Corporation

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJuly 13, 2018PRODUCT CODEBZG

Indications for use

The Chartis System is indicated for use by bronchoscopists during a bronchoscopy in adult patients with emphysema, a form of Chronic Obstructive Pulmonary Disease (COPD), in a bronchoscopy suite. The system, composed of the Chartis Catheter and Chartis Console, is designed to measure pressure and flow in order to calculate resistance to airflow and quantify collateral ventilation in isolated lung Pulmonx Chartis Tablet Console Traditional 510(k) Notification _________________________________________________________________________ ________________________________________________________________________________

Pulmonx CONFIDENTIAL Page 2

compartments. The Chartis Catheter is used through the working channel of a bronchoscope and connects to the Chartis Tablet Console. The Chartis Console is capital equipment that is reusable and displays the patient information.

Comparison of Intended Use and Technological Characteristics with the Predicate Device: The subject and the predicate devices have the same intended use as spirometry systems in measuring pressure and/or flow to detect the presence of collateral ventilation in isolated lung compartments.

The subject and predicate device are based on the following same technological elements:  Both devices operate with the Chartis Catheter as the Chartis System and have the same principles of operation.  Both devices have the same general device description. Both devices are comprised of a touchscreen computer, patient interface board and software.  Both devices display air pressure, airflow, resistance and total volume of expired air.

Whereas the predicate device is indicated for all adult patients, the indications for use for the subject device specify the intended patient population as adult patients with emphysema, a form of Chronic Obstructive Pulmonary Disease (COPD). The computer and patient interface board of the predicate device are integrated into a single unit; in the subject device they are two physically separate components. The subject device allows segmental level assessments.

The subject device additionally provides a second display option called the Ventilator Mode. The Ventilator Mode provides a display option that may be preferred when the physician selects to perform the bronchoscopy and Chartis assessment on a patient under general anesthesia with mechanical ventilation. For clarification, the term “Ventilator Mode” does not signify it is intended for use in patients that are ventilator dependent outside of the procedure. The Standard Mode, which is available in both the predicate device and the subject device, provides a display option that may be preferred when the physician selects to perform the bronchoscopy and Chartis assessment on a patient under conscious sedation with spontaneous breathing. Both modes display the flow graphs, and both modes can be used to detect the presence of collateral ventilation in isolated lung compartments. The main difference in the display of the two modes is that the Ventilator Mode does not display inspiratory pressure and resistance since these measurements are not generated when mechanical ventilation is used during the procedure.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 27, 2026